BioSpace News Archive

Biotech startup Precision Virologics, which develops adenovirus-based vaccines in St. Louis, and Bharat Biotech, a vaccine manufacturing giant, jointly obtained rights from Washington University School of Medicine in St. Louis for a novel chimp-adenovirus vaccine for COVID-19.

For several decades, veterinary vaccines have played a key role in improving food security and as a result, human health.

The global measles, mumps, and rubella vaccines market is growing on the back of remarkable growth in the number of patients with pneumococcal infections.

A handful of international and local manufacturers with limited shares dominate the global diabetic neuropathy market.

The demand in the global market for constipation treatment is projected to increment at a healthy CAGR of 7.1% during the forecast period of 2017 to 2025.

Antiviral drugs refer to those prescription medicines that are capable of fighting against flu viruses in one’s body.

Vela Diagnostics’ automated COVID-19 detection kit receives Emergency Use Authorization from the FDA.

Emergency Use Authorization request targets the same population as is currently permitted under FDA Expanded Access Protocol

Vivet Therapeutics and Pfizer Inc. announced that they have entered into a manufacturing agreement, under which Pfizer will provide clinical supply for a Phase 1/2 clinical trial evaluating Vivet’s proprietary, investigational gene therapy, VTX-801, for the potential treatment of Wilson disease, a rare and potentially life-threatening liver disorder.

Minoryx will receive an upfront and milestone payments of up to $78 million, as well as double digit royalties on annual net sales